Company Overview
WHITEHAWK THERAPEUTICS, INC.
WHWKRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
7M
2025 FY
Net Income
-21M
2025 FY
Shares Outstanding
62M
2025 FY
EPS
-0.33USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1422142
Exchange
Nasdaq
Location
US